Orgaran and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Orgaran (danaparoid sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Unasyn, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Orgaran. It is created by eHealthMe based on reports of 861 people who have side effects when taking Orgaran from the FDA, and is updated regularly.

What is Orgaran?

Orgaran has active ingredients of danaparoid sodium. eHealthMe is studying from 863 Orgaran users. Check the latest studies of Orgaran.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,950 drugs and 2,942 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

861 people reported to have side effects when taking Orgaran.
Among them, 23 people (2.67%) have Hyperkalemia.

Among these 23 people:

How long have people been on Orgaran when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Orgaran? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Hyperkalemia when taking Orgaran? *

What are other drugs people take besides Orgaran? *

What are other side effects people have besides Hyperkalemia? *

White Blood Cell Count Decreased: 11 people, 47.83%
Anaemia (lack of blood): 10 people, 43.48%
Blood Creatinine Increased: 8 people, 34.78%
Thrombocytopenia (decrease of platelets in blood): 8 people, 34.78%
Pneumonia: 7 people, 30.43%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 6 people, 26.09%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 26.09%
Pulmonary Haemorrhage (acute bleeding from the lung): 6 people, 26.09%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 6 people, 26.09%
Blood Lactate Dehydrogenase Increased: 6 people, 26.09%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 26.09%
Multiple Myeloma (cancer of the plasma cells): 4 people, 17.39%
High Blood Pressure: 4 people, 17.39%
Adverse Event: 4 people, 17.39%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 13.04%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 2 people, 8.70%
Lung Infection: 2 people, 8.70%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 8.70%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 4.35%
Pain: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Orgaran and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Orgaran:

Orgaran (863 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,085 reports)

Browse all side effects of Orgaran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,950 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,942 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on danaparoid sodium (the active ingredients of Orgaran) and Orgaran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.